- Home
- SMTI vs EDD Comparison
SMTI vs EDD Comparison
Compare SMTI & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- EDD
- Stock Information
- Founded
- SMTI 1982
- EDD 2007
- Country
- SMTI United States
- EDD United States
- Employees
- SMTI N/A
- EDD N/A
- Industry
- SMTI Medical/Dental Instruments
- EDD Finance Companies
- Sector
- SMTI Health Care
- EDD Finance
- Exchange
- SMTI Nasdaq
- EDD Nasdaq
- Market Cap
- SMTI 288.2M
- EDD 304.3M
- IPO Year
- SMTI N/A
- EDD N/A
- Fundamental
- Price
- SMTI $34.39
- EDD $4.78
- Analyst Decision
- SMTI Buy
- EDD
- Analyst Count
- SMTI 1
- EDD 0
- Target Price
- SMTI $44.00
- EDD N/A
- AVG Volume (30 Days)
- SMTI 24.7K
- EDD 254.3K
- Earning Date
- SMTI 11-12-2024
- EDD 01-01-0001
- Dividend Yield
- SMTI N/A
- EDD 7.52%
- EPS Growth
- SMTI N/A
- EDD N/A
- EPS
- SMTI N/A
- EDD N/A
- Revenue
- SMTI $72,410,222.00
- EDD N/A
- Revenue This Year
- SMTI $26.97
- EDD N/A
- Revenue Next Year
- SMTI $18.91
- EDD N/A
- P/E Ratio
- SMTI N/A
- EDD N/A
- Revenue Growth
- SMTI 21.42
- EDD N/A
- 52 Week Low
- SMTI $26.00
- EDD $4.22
- 52 Week High
- SMTI $43.25
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- SMTI 64.02
- EDD 42.55
- Support Level
- SMTI $32.91
- EDD $4.78
- Resistance Level
- SMTI $34.03
- EDD $4.78
- Average True Range (ATR)
- SMTI 1.39
- EDD 0.07
- MACD
- SMTI 0.24
- EDD 0.00
- Stochastic Oscillator
- SMTI 100.00
- EDD 55.26
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.